Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Topic: Oncology

Tumor mutational burden (TMB) and Microsatellite Instability (MSI) are now established biomarkers guiding immunotherapy decisions across a growing list of solid tumors. This article outlines how TMB and MSI are defined and assessed in VarSome...

Platform Updates Technology VarSome Clinical Oncology

Clinical Implications of TMB & MSI Biomarkers

By Jason Armstrong on May 22, 2025

Genomics and the Future of Maternal and Newborn Health: Closing Gaps, Saving Lives

Community VarSome.com News Awareness Days Oncology

World Health Day 2025 - Genomics in Maternal & Newborn Health

By Jason Armstrong on April 7, 2025

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Saphetor SA receives IVDR Certification for clinical diagnosis support NGS data analysis platform, VarSome Clinical, ensuring enhanced safety and performance standards

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Gene fusion detection: Liquid biopsies and classification of co-mutations

Company News listing page

Categories

Stay up to date

Topic: Oncology

Clinical Implications of TMB & MSI Biomarkers

World Health Day 2025 - Genomics in Maternal & Newborn Health